Nuvalent Ownership | Who Owns Nuvalent?

Nuvalent Ownership Summary

Nuvalent is owned by 10.76% institutional investors, 2.76% insiders, and 86.48% retail investors. Deerfield management company, l.p. (series c) is the largest institutional shareholder, holding 22.96% of NUVL shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.52% of its assets in Nuvalent shares.

NUVL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Nuvalent	10.76%	2.76%	86.48%
Sector	Healthcare Stocks	35.58%	11.87%	52.55%
Industry	Biotech Stocks	35.75%	11.83%	52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Deerfield management company, l.p. (series c)	17.25M	22.96%	$1.77B
Fmr	9.27M	12.35%	$950.22M
Vanguard group	5.24M	7.27%	$527.52M
Paradigm biocapital advisors lp	5.32M	7.09%	$545.49M
Blackrock funding, inc. /de	4.82M	6.42%	$494.30M
Blackrock	3.02M	4.71%	$229.37M
Jpmorgan chase	3.09M	4.11%	$298.71M
Ra capital management	2.53M	3.37%	$259.62M
Wellington management group llp	2.47M	3.29%	$253.10M
Price t rowe associates inc /md/	2.06M	2.74%	$210.65M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Deerfield management company, l.p. (series c)	17.25M	20.85%	$1.77B
Paradigm biocapital advisors lp	5.32M	11.15%	$545.49M
Commodore capital lp	833.60K	4.94%	$85.40M
Boxer capital	1.12M	4.48%	$84.98M
First turn management	370.34K	4.24%	$37.94M
Silverarc capital management	354.91K	3.71%	$36.36M
Perceptive advisors	1.58M	3.17%	$161.92M
Ra capital management	2.53M	2.75%	$259.62M
Bellevue group	1.05M	2.57%	$107.91M
Braidwell lp	700.43K	2.39%	$71.76M

Top Buyers

Holder	Shares	% Assets	Change
Deep track capital, lp	1.38M	2.30%	1.38M
Jpmorgan chase	3.09M	0.02%	883.10K
Ra capital management	2.53M	2.75%	654.09K
Vanguard group	5.24M	0.01%	639.26K
Norges bank	574.24K	0.01%	574.24K

Top Sellers

Holder	Shares	% Assets	Change
Fmr	9.27M	0.05%	-1.58M
Bain capital life sciences investors	-	-	-1.45M
Darwin global management	-	-	-1.44M
Fairmount funds management	-	-	-727.56K
Logos global management lp	-	-	-500.00K

New Positions

Holder	Shares	% Assets	Change	Value
Deep track capital, lp	1.38M	2.30%	1.38M	$141.00M
Norges bank	574.24K	0.01%	574.24K	$57.76M
Vanguard fiduciary trust	364.17K	0.01%	364.17K	$37.31M
Two sigma investments, lp	102.12K	0.01%	102.12K	$10.46M
Renaissance	89.00K	0.01%	89.00K	$9.12M

Sold Out

Holder	Change
Td private client wealth	-1.00
Dunhill financial	-1.00
Financial gravity asset management	-1.00
Sbi securities	-3.00
Ronald blue trust	-4.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	103	-56.90%	8,085,732	-89.88%	10	0.09%	60	-62.96%	22	-52.17%
Dec 31, 2025	163	-19.70%	23,806,487	-67.13%	32	0.32%	117	17.00%	24	-60.66%
Sep 30, 2025	197	-10.05%	71,933,593	0.06%	100	1.00%	98	-20.97%	60	7.14%
Jun 30, 2025	218	1.87%	71,878,154	-0.07%	100	0.99%	123	19.42%	56	-24.32%
Mar 31, 2025	17	-92.58%	31,565,284	-55.28%	44	0.38%	7	-95.17%	7	-85.71%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.49M	3.52%	-
Vanguard Total Stock Mkt Idx Inv	1.75M	2.22%	5.84K
Fidelity Growth Compy Commingled Pl S	1.37M	1.74%	-474.66K
Vanguard Small Cap Index	1.26M	1.60%	-2.52K
Fidelity Growth Company Fund	1.21M	1.54%	-253.50K
iShares Russell 2000 ETF	1.18M	1.49%	9.92K
Vanguard Health Care Inv	1.05M	1.33%	-
Polar Capital Biotech S Inc	964.07K	1.22%	64.07K
State Street® SPDR® S&P® Biotech ETF	944.02K	1.20%	-9.35K
Strategic Advisers Fidelity US TtlStk	844.55K	1.07%	56.09K

Recent Insider Transactions

Date	Name	Role	Activity	Value
May 04, 2026	Porter James Richard	President and CEO	Sell	$1.77M
May 04, 2026	Porter James Richard	President and CEO	Sell	$167.42K
May 04, 2026	Porter James Richard	President and CEO	Sell	$140.48K
May 04, 2026	Porter James Richard	President and CEO	Sell	$753.89K
May 04, 2026	Porter James Richard	President and CEO	Sell	$217.18K

Insider Transactions Trends

Date	Buy	Sell
2026 Q2	-	22
2026 Q1	-	75
2025 Q4	-	68
2025 Q3	-	32
2025 Q2	-	20

NUVL Ownership FAQ

Who Owns Nuvalent?

Nuvalent shareholders are primarily institutional investors at 10.76%, followed by 2.76% insiders and 86.48% retail investors. The average institutional ownership in Nuvalent's industry, Biotech Stocks , is 35.75%, which Nuvalent falls below.

Who owns the most shares of Nuvalent?

Nuvalent’s largest shareholders are Deerfield management company, l.p. (series c) (17.25M shares, 22.96%), Fmr (9.27M shares, 12.35%), and Vanguard group (5.24M shares, 7.27%). Together, they hold 42.58% of Nuvalent’s total shares outstanding.

Does Blackrock own Nuvalent?

Yes, BlackRock owns 4.71% of Nuvalent, totaling 3.02M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 229.37M$. In the last quarter, BlackRock increased its holdings by 315.17K shares, a 11.64% change.

Who is Nuvalent’s biggest shareholder by percentage of total assets invested?

Deerfield management company, l.p. (series c) is Nuvalent’s biggest shareholder by percentage of total assets invested, with 20.85% of its assets in 17.25M Nuvalent shares, valued at 1.77B$.

Who is the top mutual fund holder of Nuvalent shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Nuvalent shares, with 3.52% of its total shares outstanding invested in 2.49M Nuvalent shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools